Company Filing History:
Years Active: 2003
Title: Guenter Michl: Innovator in Pharmaceutical Chemistry
Introduction
Guenter Michl is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on calcium complexes. His research focuses on developing compounds that can mitigate the effects of heavy metals in medical applications.
Latest Patents
Guenter Michl holds a patent for a complex titled "CALCIUM COMPLEX OF [[(4R)-4-[BIS{CARBOXY-.KAPPA.O)METHYL]AMINO-.KAPPA.N]-6,9-BIS[(CARBOXY.KAPPA.O)METHYL]-1-[(4,4-DIPHENYLCYCLOHEXYL)OXY]-1-HYDROXY-2-OXA-6,9-DIAZA-1-PHOSPHAUNDECAN-11-YLIC-ACID-.KAPPA.N6,.KAPPA.N9,.KAPPA.011]1-OXIDATO(6-)]-, HEXAHYDROGEN, ITS SALTS, PHARMACEUTICAL AGENTS THAT CONTAIN THESE COMPLEXES, THEIR USE IN TREATMENT AND AS ADDITIVES IN DIAGNOSIS, AS WELL AS PROCESSES FOR THE PRODUCTION OF THE COMPLEXES AND AGENTS. This patent highlights his innovative approach to creating pharmaceutical agents that can be used in the treatment of conditions caused by heavy metals.
Career Highlights
Guenter Michl is associated with Schering Aktiengesellschaft, a prominent pharmaceutical company. His work there has allowed him to explore various aspects of pharmaceutical development and contribute to advancements in the field. His dedication to research and innovation has positioned him as a key figure in pharmaceutical chemistry.
Collaborations
Throughout his career, Guenter has collaborated with esteemed colleagues such as Johannes Platzek and Ulrich Niedballa. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of research.
Conclusion
Guenter Michl's contributions to pharmaceutical chemistry, particularly through his patented innovations, demonstrate his commitment to advancing medical science. His work continues to have a significant impact on the